Copyright: ©Author(s) 2026.
World J Gastroenterol. Oct 21, 2026; 32(39): 121041
Published online Oct 21, 2026. doi: 10.3748/wjg.121041
Published online Oct 21, 2026. doi: 10.3748/wjg.121041
Figure 3 Effect of metabolites with 10 μg/mL lipopolysaccharides on the barrier integrity and inflammation in the Caco-2 cells.
A: Apparent permeability coefficient (Papp) for monolayer permeability to fluorescein isothiocyanate-dextran; B: Interleukin-8 content in culture medium; C: Gene expression of tight junction proteins and pro-inflammatory cytokines. Values are shown as medians and interquartile range (from min to max). All assays were performed in three independent experiments, each with 4-9 biological replicates per group. aP < 0.05 vs the control (10 μg/mL lipopolysaccharides), bP < 0.01 vs the control (10 μg/mL lipopolysaccharides), cP < 0.05 vs lipopolysaccharides + combination of butyric, propionic, and valeric acids group, dP < 0.01 vs lipopolysaccharides + combination of butyric, propionic, and valeric acids group, Kruskal-Wallis test with post hoc Dunn’s test, corrected with Benjamini-Hochberg procedure. Papp: Apparent permeability coefficient; LPS: Lipopolysaccharides; But: Butyric acid; Prop: Propionic acid; Val: Valeric acid; BPV: Combination of butyric, propionic, and valeric acids; IL-8: Interleukin-8; TNF-α: Tumor necrosis factor-α.
- Citation: Sall T, Litvinova E, Arzhanova E, Sitkin S, Vakhitov T. Gut microbial metabolites as key mediators in inflammatory bowel disease. World J Gastroenterol 2026; 32(39): 121041
- URL: https://www.wjgnet.com/1007-9327/full/v32/i39/121041.htm
- DOI: https://dx.doi.org/10.3748/wjg.121041